Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?

M de Bruin-Weller

doi:10.1111/bjd.18037

Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	12-13
Number of pages	2
Journal	British Journal of Dermatology
Volume	181
Issue number	1
DOIs	https://doi.org/10.1111/bjd.18037
Publication status	Published - Jul 2019

Keywords

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic
Eczema
Humans
Skin

Access to Document

10.1111/bjd.18037

Cite this

@article{e00fa8c9e24a46c9bb32de3de83ea488,

title = "Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?",

keywords = "Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Dermatitis, Atopic, Eczema, Humans, Skin",

author = "{de Bruin-Weller}, M",

year = "2019",

month = jul,

doi = "10.1111/bjd.18037",

language = "English",

volume = "181",

pages = "12--13",

journal = "British Journal of Dermatology",

issn = "0007-0963",